Make saxenda available to more people on the hse drugs payment scheme

Make saxenda available to more people on the hse drugs payment scheme

The Issue

Liraglutide (also called Saxenda) is a weight loss medicine that works by making you feel fuller and less hungry. It's taken as an injection once a day.

Saxenda has been approved under the drugs payment scheme in Ireland but under very strict conditions:

Age 18 - 74 years

BMI ≥ 35 kg/m2 

Confirmation of: 

o participation in non-pharmacological interventions which includes a reduced-calorie diet

and increased physical activity e.g. HSE Diabetes Prevention Programme*

o diagnosis of prediabetes - fasting plasma glucose level between 5.5 - 6.9 mmol/L and

HbA1c level between 42 - 47 mmol/mol

o high risk of CVD - total fasting cholesterol level > 5 mmol/L, or mean systolic blood

pressure (BP) > 140 mmHg, despite pharmacological treatment

This petition is about making the drug available to more people with a bmi over 30 before they suffer side effects like high blood pressure, high cholesterol and diabetes.

The drug is currently available privately to those with a bmi of over 30 but with a price of circa €240 per month this means many people who could benefit from it cannot afford it.

224

The Issue

Liraglutide (also called Saxenda) is a weight loss medicine that works by making you feel fuller and less hungry. It's taken as an injection once a day.

Saxenda has been approved under the drugs payment scheme in Ireland but under very strict conditions:

Age 18 - 74 years

BMI ≥ 35 kg/m2 

Confirmation of: 

o participation in non-pharmacological interventions which includes a reduced-calorie diet

and increased physical activity e.g. HSE Diabetes Prevention Programme*

o diagnosis of prediabetes - fasting plasma glucose level between 5.5 - 6.9 mmol/L and

HbA1c level between 42 - 47 mmol/mol

o high risk of CVD - total fasting cholesterol level > 5 mmol/L, or mean systolic blood

pressure (BP) > 140 mmHg, despite pharmacological treatment

This petition is about making the drug available to more people with a bmi over 30 before they suffer side effects like high blood pressure, high cholesterol and diabetes.

The drug is currently available privately to those with a bmi of over 30 but with a price of circa €240 per month this means many people who could benefit from it cannot afford it.

The Decision Makers

Stephen Donnelly
Stephen Donnelly
Minister for Health

Petition Updates